ClinicalTrials.gg
CompletedNCT06307496Updated Sep 29, 2026Results posted

VIDeOS for Smoking Cessation

An interventional study of Smoking cessation intervention and Informational intervention in Cancer and Smoking Cessation, sponsored by Medical University of South Carolina. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Other

How we know

Updated Sep 29, 2026Results postedStudy documents posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of the current study is to pilot the efficacy, feasibility, and acceptability of an evidence-based smoking cessation intervention adapted for cancer patients and delivered via video. Investigators aim to assess if this intervention is considered acceptable by participants, feasible to implement, and effective at increasing knowledge about smoking cessation before conducting a fully powered clinical trial.

Read the detailed description

A randomized controlled pilot study is being conducted to test the acceptability and feasibility of a smoking cessation intervention tailored for cancer patients that is delivered via video. Participants will be in a video intervention or control group that receives information about quitting smoking. Participants will complete surveys prior to randomization, and will complete additional surveys one week, one month, and three months post-randomization to provide their thoughts about the videos, information about changes to smoking behaviors, and knowledge about quitting smoking.

02

Conditions studied

  • Cancer
  • Smoking Cessation

Keywords

  • Videos
03

In context

Neoplasms

10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.

This study's enrollment of 40 is below the median of 60 across 7,716 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 875 studies on the registry; 165 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • Diagnosed with cancer (any type)
  • Receiving care at Medical University of South Carolina
  • Reads and understands English language
  • Currently smoking cigarettes (any amount)

Exclusion criteria

Exclusion Criteria:

- Unstable or poorly managed medical or psychiatric conditions that impair cognition and ability to provide (e.g., dementia, active psychosis).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Videos

    Participants will be sent links to smoking cessation videos to watch.

    Other: Smoking cessation intervention

  • Active comparator
    NCI Pamphlet

    Participants will be sent links to NCI's "Clearing the Air" to read.

    Other: Informational intervention

Interventions

  • OtherSmoking cessation intervention

    Receive links to smoking cessation videos

  • OtherInformational intervention

    Receive NCI's "Clearing the Air" booklet

06

What researchers measure

Primary outcomes

  1. Acceptability of Intervention Measure

    Acceptability will be measured using the measure titled the "Acceptability of Intervention Measure" (AIM), which contains four items with answer options on a scale from 1-5. Higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.

    Time frame: 1 week post-randomization

  2. Feasibility of Intervention Measure

    Feasibility will be measured using the measure title the "Feasibility of Intervention Measure" (FIM), which contains four items with answer options on a scale from 1-5. Answer responses are summed and averaged. Higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained.

    Time frame: 1 week post-randomization

  3. Number of Participants Retained

    We will determine if there are differences in retention rates between intervention groups.

    Time frame: 1 week, 1 month, and 3 months post-randomization

Secondary outcomes

  1. Number of Questions About Knowledge Related to Quitting Smoking That Were Answered Correctly

    Questions about the impact of quitting smoking were asked to determine if there were numeric differences in the number of participants who answered each question correctly between intervention and control groups at 1-week follow-ups. Questions were true or false questions generated by the primary investigator. We calculated the number of participants who answered each of the three questions correctly.

    Time frame: 1 week

  2. Number of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-ups

    We calculated the number of 24-hour quit attempts made by participants in each group at the 1-week, 3-month, and 6-month follow-ups. We also calculated the number of participants who reported past 7-day point prevalence abstinence at 1-week, 1-month, and 3-month follow-ups.

    Time frame: 1 week, 1 month, and 3 months post-randomization

07

Results

Posted Sep 29, 2026

Participant flow

Participants were recruited through the Tobacco Treatment Program at the Medical University of South Carolina Hollings Cancer Center. All cancer center patients that received a call from a tobacco treatment specialist as part of the cancer center's standard of care were asked about their interest in participating in a research study, and interested patients were referred to study staff. Participants were recruited between September 2024 and June 2025.

Participant flow — Overall Study
MilestoneVideosNCI Pamphlet
Started2020
Completed2020
Not completed00

Outcome measures

PrimaryAcceptability of Intervention Measure

Acceptability will be measured using the measure titled the "Acceptability of Intervention Measure" (AIM), which contains four items with answer options on a scale from 1-5. Higher scores indicating higher acceptability. We will consider the intervention "acceptable" if an average score of 4 or higher is obtained.

Time frame:
1 week post-randomization
Reported as:
Mean · score on a scale
Acceptability of Intervention Measure
score on a scaleVideosNCI Pamphlet
Acceptability of Intervention Measure4.2 ± 0.543.9 ± 0.52
PrimaryFeasibility of Intervention Measure

Feasibility will be measured using the measure title the "Feasibility of Intervention Measure" (FIM), which contains four items with answer options on a scale from 1-5. Answer responses are summed and averaged. Higher scores indicating higher feasibility. We will consider the intervention "feasible" if an average score of 4 or higher is obtained.

Time frame:
1 week post-randomization
Reported as:
Mean · score on a scale
Feasibility of Intervention Measure
score on a scaleVideosNCI Pamphlet
Feasibility of Intervention Measure4.0 ± 0.533.8 ± 0.45
PrimaryNumber of Participants Retained

We will determine if there are differences in retention rates between intervention groups.

Time frame:
1 week, 1 month, and 3 months post-randomization
Reported as:
Number · participants
Number of Participants Retained
participantsVideosNCI Pamphlet
1-week retention1816
1-month retention1412
3-months retention1512
SecondaryNumber of Questions About Knowledge Related to Quitting Smoking That Were Answered Correctly

Questions about the impact of quitting smoking were asked to determine if there were numeric differences in the number of participants who answered each question correctly between intervention and control groups at 1-week follow-ups. Questions were true or false questions generated by the primary investigator. We calculated the number of participants who answered each of the three questions correctly.

Time frame:
1 week
Reported as:
Number · participants
Number of Questions About Knowledge Related to Quitting Smoking That Were Answered Correctly
participantsVideosNCI Pamphlet
Smoking impact on anxiety question correct128
Smoking impact on cancer treatment correct1815
Safe to use multiple forms of NRT correct108
SecondaryNumber of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-ups

We calculated the number of 24-hour quit attempts made by participants in each group at the 1-week, 3-month, and 6-month follow-ups. We also calculated the number of participants who reported past 7-day point prevalence abstinence at 1-week, 1-month, and 3-month follow-ups.

Time frame:
1 week, 1 month, and 3 months post-randomization
Reported as:
Number · participants
Number of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-ups
participantsVideosNCI Pamphlet
1-week quit attempts45
1-month quit attempts64
3-month quit attempts87
1-week abstinence13
1-month abstinence02
3-months abstinence22

Adverse events

Collected over Adverse events were not collected given the study was a low-risk behavioral intervention study assessing acceptability and feasibility of using video for smoking cessation.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Videos———
NCI Pamphlet———

Baseline characteristics

Two participants that completed baseline surveys were considered randomized non-starters given they did not receive or participate in study procedures due to dropout or death. Their data were not analyzed with the rest of the sample.

Age, Continuous
Age, Continuous(years)VideosNCI PamphletTotal
Mean54.7 ± 1059.6 ± 6.857.1 ± 8.8
Sex: Female, Male
Sex: Female, Male(Participants)VideosNCI PamphletTotal
Female12820
Male81220
Race (NIH/OMB)
Race (NIH/OMB)(Participants)VideosNCI PamphletTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American9817
White101121
More than one race112
Unknown or Not Reported000
Rural/Urban Residence
Rural/Urban Residence(Participants)VideosNCI PamphletTotal
Rural7714
Urban131326
08

Study locations

1 site
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2024 to primary completion in Sep 2025, 11 months.

Results were first posted in Sep 2026, 1 year after primary completion.

Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's 11 months is below that.

Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2024
First posted
Mar 12, 2024
StartActual
Sep 24, 2024
Primary completionActual
Sep 10, 2025
CompletionActual
Sep 10, 2025
Results first posted
Sep 29, 2026
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Sep 29, 2026
Enrollment
42→40
Sep 29, 2026
Primary outcomes
1 edited, 2 added, 2 removed
What changed in the outcomes
  • ChangedBefore Retention RatesNow Number of Participants RetainedTime frame: 1 week, 1 month, and 3 months post-randomization
  • AddedAcceptability of Intervention MeasureTime frame: 1 week post-randomization
  • AddedFeasibility of Intervention MeasureTime frame: 1 week post-randomization
  • RemovedAcceptabilityTime frame: 1 week post-randomization
  • RemovedFeasibilityTime frame: 1 week post-randomization
Sep 29, 2026
Documents
Secondary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedNumber of Questions About Knowledge Related to Quitting Smoking That Were Answered CorrectlyTime frame: 1 week
  • AddedNumber of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-upsTime frame: 1 week, 1 month, and 3 months post-randomization
  • RemovedChanges in knowledge about quitting smokingTime frame: Baseline, 1 week, 1 month, and 3 months post-randomization
  • RemovedChanges in smoking behaviorsTime frame: 1 week, 1 month, and 3 months post-randomization
Sep 29, 2026
Sponsor
Collaborators added: Alliance for Clinical Trials in Oncology
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Results posted
    Enrollment 42→40
    Primary outcomes 1 edited, 2 added, 2 removed
    What changed in the outcomes
    • ChangedBefore Retention RatesNow Number of Participants RetainedTime frame: 1 week, 1 month, and 3 months post-randomization
    • AddedAcceptability of Intervention MeasureTime frame: 1 week post-randomization
    • AddedFeasibility of Intervention MeasureTime frame: 1 week post-randomization
    • RemovedAcceptabilityTime frame: 1 week post-randomization
    • RemovedFeasibilityTime frame: 1 week post-randomization
    Secondary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedNumber of Questions About Knowledge Related to Quitting Smoking That Were Answered CorrectlyTime frame: 1 week
    • AddedNumber of Participants Who Made Quit Attempts and Achieved Smoking Abstinence at 1-week, 1-month, and 3-month Follow-upsTime frame: 1 week, 1 month, and 3 months post-randomization
    • RemovedChanges in knowledge about quitting smokingTime frame: Baseline, 1 week, 1 month, and 3 months post-randomization
    • RemovedChanges in smoking behaviorsTime frame: 1 week, 1 month, and 3 months post-randomization
    Sponsor Collaborators added: Alliance for Clinical Trials in Oncology
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06307496
Responsible party
Kinsey Pebley (Assistant Professor, University of Kansas Medical Center) — Principal investigator
First posted
Mar 12, 2024
Start date
Sep 24, 2024
Primary completion
Sep 10, 2025
Completion
Sep 10, 2025
Results posted
Sep 29, 2026
Last update
Sep 29, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion